Dr Marcal is also translating biomedical applications in autoimmune arthritis. These are inflammatory arthritis conditions associated with individuals that are positive for the HLA-B27 phenotype and susceptible for autoimmune tissue destruction. This technology leads the field for the development of a biotherapeutic to help halt the immuno-pathogenesis of these conditions. Dr. Marçal has been a finalist for inventor of the year UNSW Australia. His research has been highlighted in the Sydney Morning Herald, National Geographic, Discovery Channel, ABC Catalyst, The Sunday Telegraph, NASA TV, New York Times, to name a few.

He has established international collaborations involving these technologies in the field of regenerative and translational medicine and presents at numerous international conferences. Dr. Marçal’s knowledge and skills span across innovative areas and he holds 7 patents in these fields. Dr. Helder Marcal specializes in tissue regeneration in Space Medicine and the impact of space travel on human physiology (mission to Mars) especially, the impact of microgravity and its effect on stem cells and tissue regeneration. Dr. Marcal introduced the area of Bioastronautics to Australia at the Powerhouse Museum in collaboration with NASA. He has been a visiting fellow at Harvard-MIT Health Sciences and Technology, McGowan Institute for Regenerative Medicine, European Stem Cell Centre of Excellence, and the Californian Institute for Regenerative Medicine.